Caen University Hospital, Department of Pharmacology
Caen, Normandy, 14033, France
NCT Number: NCT05234333
COVID-19 vaccines induced malaise have recently been reported in the literature. Our study aims to identify risk factors associated with the onset of COVID-19 vaccines induced malaise and to assess if certain COVID-19 vaccines could be more prone to cause malaise compared to influenza vaccines.
To do so we performed a disproportionality analysis adjusted on age class, sex, region and type of reporter in VigiBase®, the WHO pharmacovigilance database, restricted to data from 01/01/2021 to 26/01/2022 to assess the association between all COVID-19 vaccines on the market and malaise. Demographic data were also analyzed.
Looking for future studies?
Notify MeAll sexes
Observational
Caen, Normandy, 14033, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SARS-CoV-2 vaccination
Time frame: from the 01/01/2021 to the 26/01/2022
case/no case study
University Hospital, Caen
Other
COVID-19 Vaccines Induced Malaise: A Retrospective Study and Analysis of the WHO Pharmacovigilance Database
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05898464
Infections, Vaccination; Infection
Seoul, South Korea
View Trial DetailsNCT05283902
COVID-19, Coronaviridae Infections
Vitória, Espírito Santo, Brazil
View Trial DetailsNCT05546502
Vaccine Adverse Reaction, Vaccine Reaction
Denpasar, Bali, Indonesia
View Trial DetailsNCT04380701
COVID-19, Coronaviridae Infections
Berlin, Germany
View Trial Details